KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hologic (HOLX) EBIT (2016 - 2025)

Hologic's EBIT history spans 17 years, with the latest figure at $237.0 million for Q4 2025.

  • For Q4 2025, EBIT rose 3.13% year-over-year to $237.0 million; the TTM value through Dec 2025 reached $721.5 million, down 21.08%, while the annual FY2025 figure was $714.3 million, 19.07% down from the prior year.
  • EBIT for Q4 2025 was $237.0 million at Hologic, roughly flat from $236.9 million in the prior quarter.
  • Across five years, EBIT topped out at $796.8 million in Q1 2021 and bottomed at -$7.0 million in Q1 2025.
  • The 5-year median for EBIT is $240.5 million (2024), against an average of $286.9 million.
  • The largest annual shift saw EBIT surged 17328.57% in 2024 before it crashed 103.33% in 2025.
  • A 5-year view of EBIT shows it stood at $641.3 million in 2021, then tumbled by 59.08% to $262.4 million in 2022, then fell by 24.47% to $198.2 million in 2023, then increased by 15.94% to $229.8 million in 2024, then grew by 3.13% to $237.0 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's EBIT are $237.0 million (Q4 2025), $236.9 million (Q3 2025), and $254.6 million (Q2 2025).